Stanford University
Showing 91-100 of 133 Results
-
Richard J. Reimer, MD
Associate Professor of Neurology and Neurological Sciences (Adult Neurology)
Current Research and Scholarly InterestsReimer Lab interests
A primary interest of our lab is to understand how nerve cells make and recycle neurotransmitters, the small molecules that they use to communicate with each other. In better defining these processes we hope to achieve our long-term goal of identifying novel sites for treatment of diseases such as epilepsy and Parkinson Disease. In our studies on neurotransmitter metabolism we have focused our efforts on transporters, a functional class of proteins that move neurotransmitters and other small molecules across membranes in cells. Transporters have many characteristics that make them excellent pharmacological targets, and not surprisingly some of the most effective treatments for neuropsychiatric disorders are directed at transporters. We are specifically focusing on two groups of transporters vesicular neurotransmitter transporters that package neurotransmitters into vesicles for release, and glutamine transporters that shuttle glutamine, a precursor for two major neurotransmitters glutamate and GABA, to neurons from glia, the supporting cells that surround them. We are pursuing these goals through molecular and biochemical studies, and, in collaboration with the Huguenard and Prince labs, through physiological and biosensor based imaging studies to better understand how pharmacological targeting of these molecules will influence neurological disorders.
A second interest of our lab is to define mechanism underlying the pathology of lysosomal storage disorders. Lysosomes are membrane bound acidic intracellular organelles filled with hydrolytic enzymes that normally function as recycling centers within cells by breaking down damaged cellular macromolecules. Several degenerative diseases designated as lysosomal storage disorders (LSDs) are associated with the accumulation of material within lysosomes. Tay-Sachs disease, Neimann-Pick disease and Gaucher disease are some of the more common LSDs. For reasons that remain incompletely understood, these diseases often affect the nervous system out of proportion to other organs. As a model for LSDs we are studying the lysosomal free sialic acid storage disorders. These diseases are the result of a defect in transport of sialic acid across lysosomal membranes and are associated with mutations in the gene encoding the sialic acid transporter sialin. We are using molecular, genetic and biochemical approaches to better define the normal function of sialin and to determine how loss of sialin function leads to neurodevelopmental defects and neurodegeneration associated with the lysosomal free sialic acid storage disorders. -
Eric Rider, MD
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Rider is a board-certified, fellowship-trained neuromuscular neurologist with the Neuromuscular Program at the Stanford Neuroscience Health Center. He is also a clinical assistant professor in the Department of Neurology & Neurological Sciences at Stanford University School of Medicine.
Dr. Rider specializes in treating neuromuscular disease, including motor neuron disease, disorders of the neuromuscular junction, peripheral and focal neuropathies, as well as other acquired or genetic conditions that cause muscular deterioration, muscle weakness, and nerve damage. He practices both Comprehensive Neurology and Neuromuscular Medicine in Palo Alto and Emeryville.
Dr. Rider earned his medical degree at the University of California, San Francisco and completed residency at Stanford. He also completed fellowship training in Neuromuscular Medicine at UCSF. He has a passion for teaching neurology to students and patients. He was awarded the Fishers and Dunn teaching award for medical student teaching as a resident.
Dr. Rider is a member of the American Academy of Neurology and American Association of Neuromuscular & Electrodiagnostic Medicine. -
Lucia Angelica Rivera Lara, MD, MPH
Clinical Associate Professor, Neurology & Neurological Sciences
BioDr. Rivera-Lara is a neurocritical care fellowship-trained neurologist and a clinical associate professor in the Department of Neurology at Stanford University School of Medicine.
As a member of the neurocritical care team, Dr. Rivera-Lara expertise focuses on the prompt, careful assessment and treatment of patients who suffer stroke, cerebral hemorrhage, and seizures.
In her research, Dr. Rivera-Lara has studied innovations to control blood flow and relieve intracranial pressure in patients with hemorrhage. Her findings have been published in journals including Critical Care Medicine, Neurocritical Care, Stroke, Seizure, the Journal of Neurosurgery and Anesthesiology, JAMA, and presented at the International Stroke Conference, the Critical Care Conference, and at meetings of the American Academy of Neurology and Neurocritical Care Society.
She has co-authored book chapters on stroke management, neurocritical patient monitoring, antiepileptic drug therapies, brain injury after cardiac arrest, and other topics. In addition, she has served as an editorial reviewer for publications including Neurology, Critical Care Medicine, the Journal of Critical Care, Neurocritical Care and Frontiers of Neurology.
Dr. Rivera-Lara earned a Clinical Reaserch Fellowship Training award from the American Academy of Neurology and American Brain Foundation. She was nominated for the Best Consulting Physician Award, one of only a few clinical honors bestowed annually on physicians and care teams by Johns Hopkins Medicine.
She has served on the INCC committee (Inclusion for Neurocritical Care) at the Neurocritical Care Society since 2021. She is a member of the Latino Faculty Advocacy Group (LFAM) at Stanford Hospital and a Career Advisor for The Latino Medical School Association (LMSA) Neuro Specialty Section Team. She is also a Global Health Faculty Fellow at Stanford University for her work in eliminating health disparities in Latin America. She founded “Conferencias de Cuidado Neurocrítico,” which are bimonthly lectures in Neurocritical Care Emergencies and Stroke Management in Spanish via Zoom, with an audience of more than 100 doctors from Latin American countries such as Mexico, Guatemala, Colombia, Paraguay, Bolivia, Argentina, and others. -
Zachary T. Roberts, MD
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Zach Roberts is a board-certified neurologist and epileptologist with Stanford Health Care’s Comprehensive Neurology Program. He is also a clinical assistant professor in the Department of Neurology & Neurological Sciences. He completed two years of epilepsy fellowship training at New York University Langone Health where he gained extensive experience using neuromodulatory devices and managing epilepsy that is difficult to treat. Prior to this fellowship, he completed his neurology residency at the University of Pennsylvania.
Dr. Roberts specializes in caring for patients with epilepsy. He creates personalized, comprehensive care plans tailored to each patient’s unique needs. He is skilled in the use of neuromodulatory devices for treating epilepsy, including vagal nerve stimulation (VNS), responsive neurostimulation (RNS), and deep brain stimulation (DBS). His additional clinical interests include the interpretation of electroencephalography (EEG) studies as well as the treatment of sleep disorders.
Dr. Roberts has had a passion for medical education throughout his training as a doctor. He has taught and created content related to neurology and epilepsy for medical students, residents, fellows, and patients. He has designed a simulation-based learning module for the treatment of prolonged seizures and lectured on neurology for a physician assistant program in Pennsylvania. He is dedicated to advancing the knowledge of both his peers and patients.
His research interests include quality improvement as well as using technology to aid health care delivery—both in treating epilepsy and in the field of neurology. Dr. Roberts’ work has been featured on posters presented at national and international conferences. He has also published a peer-reviewed journal article on doctors’ experiences with teleneurology in Telemedicine and e-Health.
Dr. Roberts is an active member of the American Academy of Neurology, the American Medical Association, and the American Epilepsy Society. -
Zahra Sadat-Hossieny, MD
Clinical Assistant Professor, Neurology & Neurological Sciences
BioZahra Sadat-Hossieny, MD, is a board-certified neurologist who completed her fellowship in clinical epilepsy at Stanford University Hospitals and Clinics. She finished her residency in neurology at the Ohio State University Wexner Medical Center. She obtained her medical degree and a certificate in global health from the George Washington University School of Medicine and Health Sciences.
She has extensive experience treating patients with epilepsy and currently provides care through the Comprehensive Epilepsy and Comprehensive Neurology Programs at Stanford Health Care. In addition to her clinical responsibilities, Dr. Sadat-Hossieny also teaches future generations of clinicians as an assistant professor at Stanford School of Medicine in the Department of Neurology, Epilepsy, and Comprehensive Neurology.
Dr. Sadat-Hossieny has authored several peer-reviewed journal articles and book chapters. She has presented her research orally and through posters at various conferences. During her fellowship at Stanford University Hospitals and Clinics, she used advanced diagnostic techniques including video-EEG monitoring, computerized brainwave mapping, diagnostic imaging, neuropsychiatric testing, and functional mapping to accurately diagnose epilepsy and conditions imitating epilepsy. She also gained expertise in the most advanced forms of epilepsy treatment including neuromodulation, epilepsy surgery and medications specific to epilepsy. Her research focused on the cognitive effects of anti-seizure medications on patients with epilepsy and their children. She has also published on the importance of nutrient supplementation on cognition in patients taking anti-seizure medications. Her collaborations include projects that assess and improve patients’ understanding of their own seizure types. -
Sarada Sakamuri, MD
Clinical Associate Professor, Neurology & Neurological Sciences
Clinical Associate Professor (By courtesy), NeurosurgeryBioDr. Sarada Sakamuri specializes in neuromuscular medicine. Her interests are peripheral nerve injury, neuromuscular ultrasound, EMG/NCS, and neurogenetic disorders. Her other passion is graduate medical education.
She graduated from Rutgers University with Phi Beta Kappa distinction and a degree in psychology. She attended Rutgers New Jersey Medical School in Newark, NJ, where she led multiple community service and medical education activities and was elected to the Alpha Omega Alpha and Gold Humanism Honor Societies. She moved to the Bay Area to pursue neurology residency at Stanford, where she later served as chief resident. She then completed two years of fellowship in EMG/Clinical Neurophysiology and Neuromuscular Medicine and research training at Forbes Norris MDA/ALS Research Center.
Dr. Sakamuri's passion is neuromuscular medicine, with a focus on peripheral nerve traumas and disorders. She is Co-Director of the Center for Peripheral Nerve Surgery along with neurosurgeon Dr. Thomas J. Wilson. She performs advanced evaluations of peripheral nerve conditions by integrating nerve and muscle ultrasound and neurophysiologic testing (EMG/NCS) at the bedside. She has advanced training in nerve and muscle ultrasound, and sits on the Neuromuscular Ultrasound Committee of the American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM).
She is board-certified in Neurology and in Neuromuscular disorders by the American Board of Psychiatry and Neurology (ABPN). She is certified in EMG/NCS by the American Board of Electrodiagnostic Medicine (ABEM), and holds a Certificate of Added Qualification in Neuromuscular Ultrasound.
Dr. Sakamuri's other passion is graduate medical education. She is the Program Director of the Stanford Neuromuscular Medicine Fellowship and Associate Director of the Clinical Neurophysiology/EMG Fellowship, with a total of five ACGME-accredited positions filled by extremely bright and talented fellows. She supervises a weekly neurology resident continuity clinic and enjoys teaching medical students and neurology and physiatry residents and fellows. She been awarded the Lysia S. Forno Award for outstanding contributions to resident teaching. -
Jacinda Sampson
Clinical Professor, Neurology & Neurological Sciences
BioDr. Jacinda Sampson received her MD and a PhD in biochemistry from University of Alabama at Birmingham, and completed her neurology residency and neurogenetics fellowship at the University of Utah. She served at Columbia University Medical Center prior to joining Stanford University Medical Center in 2015. Her areas of interest include myotonic dystrophies, Duchenne muscular dystrophy, and neurogenetic disorders such as neurofibromatosis, hereditary spastic paraparesis, spinocerebellar ataxia, among others. She is interested in clinical trials for treatment of neurogenetic disorders, and in the clinical application of next-generation genomic sequencing to genetic testing.
